Botanical species · safety record

Canna indica

The EFSA Compendium of Botanicals holds 4 constituent measurements for Canna indica. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Canna indica L.

4Constituent measurements
0Safety records
4Cited sources
0Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Alkaloids1
  • Calcium oxalate1
  • Lectins1
  • Phenylpropanoids1

Plant parts

  • Roots and other underground parts2
  • Leaves1
  • Seed1

Preparations

  • Drying (dehydration)1
  • Solvent extraction1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
PhenylpropanoidsRoots and other underground partsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
AlkaloidsRoots and other underground partsHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Calcium oxalateLeavesDrying (dehydration)IR and Raman SpectroscopyNo resolvable identifier
LectinsSeedElectrophoretical testsNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Sook Yun, Y., Satake, M., Katsuki, S., Kunugi, A. Phenylpropanoid derivatives from edible canna, Canna edulis. Phytochemistry, 2004, vol. 65, no. 14, p. 2167-2171. DOI
  2. Baran, Enrique J., Gonzalez-Baro, Ana C., Ciciarelli, Maria M., Rolleri, Cristina H. Characterization of biominerals in species of Canna (Cannaceae). REVISTA DE BIOLOGIA TROPICAL, 2010, vol. 58, no. 4, p. 1507-1515.
  3. Darsini, I.P., Shamshad, S., John Paul, M. Canna Indica (L.): A plant with potential healing powers: A review. International journal of pharma and bio sciences, 2015, vol. 6, no. 2, p. B1-B8.
  4. Araujo, Theolyta S., Teixeira, Claudener S., Falcao, Maria A. P., Junior, Vanir R. Pinto., Santiago, Mayara Quiroz., Benevides, Raquel G., Delatorre, Plinio., Martins, Jorge L., Alexandre-Moreira, Magna S., Cavada, Benildo S., et al. Anti-inflammatory and Antinociceptive Activity of Chitin-binding Lectin from Canna Limbata Seeds. Applied biochemistry and biotechnology, 2013, p. 1944-1955.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue